Coloplast Makes More Products, Emits Less CO2

HMLEBAEK, Denmark, December 14, 2011 -

For the first time, the medical device company Coloplast sets a target for reducing its CO₂ emissions from production. The goal is an absolute reduction of 10 percent* in the next three years.

To view the Multimedia News Release, please click:

multivu.prnewswire.com/mnr/prne/coloplastas/52802/

“Even though we expect an 8 percent increase in production, we aim to reduce our total CO₂ emissions by 10 percent within the next three years,” says Allan Rasmussen, SVP Global Operations.

CO₂ reductions lead to cost savings

Coloplast is determined to increase efficiency and thereby reduce emissions.

“Production is one of the areas where Coloplast inevitably will emit CO₂, but through moderate investments in energy efficiency measures, we actually get cost savings while minimizing our environmental impact,” says Allan Rasmussen.

From air to sea

Transportation is another area with big potential CO₂ reductions.

“Today, airfreight only makes up a few percent of our total transportation, but it remains the biggest source of CO₂ emissions from our transportation. That’s why we are working to shift transport from flights to sea carriage to the greatest extent possible,” says Allan Rasmussen.

More information

You can download the Corporate Responsibility Report here:

www.coloplast.com/About/responsibility/Documents/Coloplast_CS_Report_10_2011_FINAL.pdf

Visit Coloplast corporate website at www.coloplast.com

Read the Coloplast Full Year Financial results 2010/2011 at www.coloplast.com/about/news/2011-q4-announcement

* Coloplast’s total CO₂ compared to the GHG protocol Scope 1 and Scope 2.

Coloplast facts:

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care, urology and continence care, and wound and skin care. We operate globally and employ more than 7,500 people.

PRESS CONTACT
Ulla Lundhus
Media Relations Manager
+45-4911-1929
dkul@coloplast.com

INVESTOR RELATIONS
Ian Christensen
Director of Investor Relations
+45-4911-1301
dkisec@coloplast.com

Video: multivu.prnewswire.com/mnr/prne/coloplastas/52802/